Tracking fusion of human mesenchymal stem cells after transplantation to the heart

Brian T. Freeman, Nicholas A. Kouris, Brenda M. Ogle

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Evidence suggests that transplanted mesenchymal stem cells (MSCs) can aid recovery of damaged myocardium caused by myocardial infarction. One possible mechanism for MSC-mediated recovery is reprogramming after cell fusion between transplanted MSCs and recipient cardiac cells. We used a Cre/LoxP-based luciferase reporter system coupled to biophotonic imaging to detect fusion of transplanted human pluripotent stem cell-derived MSCs to cells of organs of living mice. Human MSCs, with transient expression of a viral fusogen, were delivered to the murine heart via a collagen patch. At 2 days and 1 week later, living mice were probed for bioluminescence indicative of cell fusion. Cell fusion was detected at the site of delivery (heart) and in distal tissues (i.e., stomach, small intestine, liver). Fusion was confirmed at the cellular scale via fluorescence in situ hybridization for human-specific and mouse-specific centromeres. Human cells in organs distal to the heart were typically located near the vasculature, suggesting MSCs and perhaps MSC fusion products have the ability to migrate via the circulatory system to distal organs and engraft with local cells. The present study reveals previously unknown migratory patterns of delivered human MSCs and associated fusion products in the healthy murine heart. The study also sets the stage for follow-on studies to determine the functional effects of cell fusion ina model of myocardial damage or disease.

Original languageEnglish (US)
Pages (from-to)685-694
Number of pages10
JournalStem Cells Translational Medicine
Volume4
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Mesenchymal Stem Cell Transplantation
Mesenchymal Stromal Cells
Cell Fusion
Pluripotent Stem Cells
Centromere
Cardiovascular System
Luciferases
Fluorescence In Situ Hybridization
Small Intestine
Stomach
Myocardium
Collagen
Myocardial Infarction

Keywords

  • Cardiac patch
  • Cell fusion
  • Cell transplantation
  • Cre/LoxP
  • Mesenchymal stem cells

Cite this

Tracking fusion of human mesenchymal stem cells after transplantation to the heart. / Freeman, Brian T.; Kouris, Nicholas A.; Ogle, Brenda M.

In: Stem Cells Translational Medicine, Vol. 4, No. 6, 01.01.2015, p. 685-694.

Research output: Contribution to journalArticle

@article{5b8a663f99204d65addddad0ba6e0ee5,
title = "Tracking fusion of human mesenchymal stem cells after transplantation to the heart",
abstract = "Evidence suggests that transplanted mesenchymal stem cells (MSCs) can aid recovery of damaged myocardium caused by myocardial infarction. One possible mechanism for MSC-mediated recovery is reprogramming after cell fusion between transplanted MSCs and recipient cardiac cells. We used a Cre/LoxP-based luciferase reporter system coupled to biophotonic imaging to detect fusion of transplanted human pluripotent stem cell-derived MSCs to cells of organs of living mice. Human MSCs, with transient expression of a viral fusogen, were delivered to the murine heart via a collagen patch. At 2 days and 1 week later, living mice were probed for bioluminescence indicative of cell fusion. Cell fusion was detected at the site of delivery (heart) and in distal tissues (i.e., stomach, small intestine, liver). Fusion was confirmed at the cellular scale via fluorescence in situ hybridization for human-specific and mouse-specific centromeres. Human cells in organs distal to the heart were typically located near the vasculature, suggesting MSCs and perhaps MSC fusion products have the ability to migrate via the circulatory system to distal organs and engraft with local cells. The present study reveals previously unknown migratory patterns of delivered human MSCs and associated fusion products in the healthy murine heart. The study also sets the stage for follow-on studies to determine the functional effects of cell fusion ina model of myocardial damage or disease.",
keywords = "Cardiac patch, Cell fusion, Cell transplantation, Cre/LoxP, Mesenchymal stem cells",
author = "Freeman, {Brian T.} and Kouris, {Nicholas A.} and Ogle, {Brenda M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.5966/sctm.2014-0198",
language = "English (US)",
volume = "4",
pages = "685--694",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Tracking fusion of human mesenchymal stem cells after transplantation to the heart

AU - Freeman, Brian T.

AU - Kouris, Nicholas A.

AU - Ogle, Brenda M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Evidence suggests that transplanted mesenchymal stem cells (MSCs) can aid recovery of damaged myocardium caused by myocardial infarction. One possible mechanism for MSC-mediated recovery is reprogramming after cell fusion between transplanted MSCs and recipient cardiac cells. We used a Cre/LoxP-based luciferase reporter system coupled to biophotonic imaging to detect fusion of transplanted human pluripotent stem cell-derived MSCs to cells of organs of living mice. Human MSCs, with transient expression of a viral fusogen, were delivered to the murine heart via a collagen patch. At 2 days and 1 week later, living mice were probed for bioluminescence indicative of cell fusion. Cell fusion was detected at the site of delivery (heart) and in distal tissues (i.e., stomach, small intestine, liver). Fusion was confirmed at the cellular scale via fluorescence in situ hybridization for human-specific and mouse-specific centromeres. Human cells in organs distal to the heart were typically located near the vasculature, suggesting MSCs and perhaps MSC fusion products have the ability to migrate via the circulatory system to distal organs and engraft with local cells. The present study reveals previously unknown migratory patterns of delivered human MSCs and associated fusion products in the healthy murine heart. The study also sets the stage for follow-on studies to determine the functional effects of cell fusion ina model of myocardial damage or disease.

AB - Evidence suggests that transplanted mesenchymal stem cells (MSCs) can aid recovery of damaged myocardium caused by myocardial infarction. One possible mechanism for MSC-mediated recovery is reprogramming after cell fusion between transplanted MSCs and recipient cardiac cells. We used a Cre/LoxP-based luciferase reporter system coupled to biophotonic imaging to detect fusion of transplanted human pluripotent stem cell-derived MSCs to cells of organs of living mice. Human MSCs, with transient expression of a viral fusogen, were delivered to the murine heart via a collagen patch. At 2 days and 1 week later, living mice were probed for bioluminescence indicative of cell fusion. Cell fusion was detected at the site of delivery (heart) and in distal tissues (i.e., stomach, small intestine, liver). Fusion was confirmed at the cellular scale via fluorescence in situ hybridization for human-specific and mouse-specific centromeres. Human cells in organs distal to the heart were typically located near the vasculature, suggesting MSCs and perhaps MSC fusion products have the ability to migrate via the circulatory system to distal organs and engraft with local cells. The present study reveals previously unknown migratory patterns of delivered human MSCs and associated fusion products in the healthy murine heart. The study also sets the stage for follow-on studies to determine the functional effects of cell fusion ina model of myocardial damage or disease.

KW - Cardiac patch

KW - Cell fusion

KW - Cell transplantation

KW - Cre/LoxP

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=84930518096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930518096&partnerID=8YFLogxK

U2 - 10.5966/sctm.2014-0198

DO - 10.5966/sctm.2014-0198

M3 - Article

C2 - 25848121

AN - SCOPUS:84930518096

VL - 4

SP - 685

EP - 694

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 6

ER -